Safe Use of Contrast Media: What the Radiologist Needs to Know

被引:234
作者
Beckett, Katrina R. [1 ]
Moriarity, Andrew K. [1 ]
Langer, Jessica M. [1 ]
机构
[1] UCLA Hlth Syst, Dept Radiol Sci, Los Angeles, CA 90095 USA
关键词
NEPHROGENIC SYSTEMIC FIBROSIS; ACUTE KIDNEY INJURY; ALLERGIC-LIKE REACTIONS; ADVERSE-REACTIONS; SERUM CREATININE; POWER INJECTION; GADOLINIUM; RISK; AGENTS; CT;
D O I
10.1148/rg.2015150033
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
100231 [临床病理学]; 100902 [航空航天医学];
摘要
Iodinated and gadolinium-based contrast media are used on a daily basis in most radiology practices. These agents often are essential to providing accurate diagnoses, and are nearly always safe and effective when administered correctly. However, reactions to contrast media do occur and can be life threatening. Therefore, it is critical for faculty and staff to know how reactions to contrast agents manifest and how to treat them promptly. The decline in renal function seen occasionally after intravenous administration of iodinated contrast agents is poorly understood and likely multifactorial, and its association with the contrast medium may be overemphasized. However, it is important that radiologists be aware of current understanding and strategies to decrease the incidence of renal dysfunction. Nephrogenic systemic fibrosis, a skin disease, is an adverse reaction related to use of some gadolinium-based contrast agents in patients with chronic renal failure. The types of gadolinium most often associated with this condition and the indications for withholding gadolinium are important and are discussed in this article. The use of enteric contrast agents and contrast agents during pregnancy and nursing are reviewed briefly. Current knowledge for safe use of contrast media and key concepts that all radiologists should know are summarized in this review. (C) RSNA, 2015.
引用
收藏
页码:1738 / 1750
页数:13
相关论文
共 95 条
[1]
ALMEN T, 1994, INVEST RADIOL, V29, pS37
[2]
American College of Radiology, ACR SPR PRACT GUID U
[3]
[Anonymous], 2013, ACR MAN CONTR MED VE
[4]
Intravenous Contrast Medium Administration and Scan Timing at CT: Considerations and Approaches [J].
Bae, Kyongtae T. .
RADIOLOGY, 2010, 256 (01) :32-61
[5]
Drug therapy - Metformin [J].
Bailey, CJ ;
Turner, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (09) :574-579
[6]
Bartlett Murray J, 2003, Australas Radiol, V47, P363, DOI 10.1046/j.1440-1673.2003.01203.x
[7]
Late adverse reactions to intravascular iodine based contrast media: an update [J].
Bellin, Marie-France ;
Stacul, Fulvio ;
Webb, Judith A. W. ;
Thomsen, Henrik S. ;
Morcos, Sameh K. ;
Almen, Torsten ;
Aspelin, Peter ;
Clement, Olivier ;
Heinz-Peer, Gertraud ;
Reimer, Peter ;
van der Molen, Aart .
EUROPEAN RADIOLOGY, 2011, 21 (11) :2305-2310
[8]
Informed Consent for Contrast Media and Gadolinium Injections [J].
Berlin, Leonard .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2011, 197 (02) :W359-W359
[9]
Nephrogenic systemic fibrosis: A systemic fibrosing disease resulting from gadolinium exposure [J].
Bernstein, Elana J. ;
Schmidt-Lauber, Christian ;
Kay, Jonathan .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2012, 26 (04) :489-503
[10]
Current status of nephrogenic systemic fibrosis [J].
Besheli, L. Daftari ;
Aran, S. ;
Shaqdan, K. ;
Kay, J. ;
Abujudeh, H. .
CLINICAL RADIOLOGY, 2014, 69 (07) :661-668